Form 8-K - Current report:
SEC Accession No. 0001206774-21-000671
Filing Date
2021-03-11
Accepted
2021-03-11 16:20:27
Documents
14
Period of Report
2021-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3882181-8k.htm   iXBRL 8-K 23751
2 PRESS RELEASE DATED MARCH 11, 2021 geron3882181-ex991.htm EX-99.1 69744
6 GRAPHIC geron3882181-8kx5x1.jpg GRAPHIC 4104
  Complete submission text file 0001206774-21-000671.txt   286381

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20210311.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20210311_pre.xml EX-101.PRE 22704
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20210311_lab.xml EX-101.LAB 34591
7 EXTRACTED XBRL INSTANCE DOCUMENT geron3882181-8k_htm.xml XML 3602
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 21733566
SIC: 2834 Pharmaceutical Preparations